Mallory I. Frederick
Montreal, QC H3C3T5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.
Journal: NPJ breast cancer
Published: November 30, 2025
LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance.
Journal: Molecular & cellular proteomics : MCP
Published: June 02, 2025
Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancer.
Journal: Translational oncology
Published: October 05, 2024
Leveraging PARP-1/2 to Target Distant Metastasis.
Journal: International journal of molecular sciences
Published: July 22, 2024
Metabolic adaptation in epithelial ovarian cancer metastasis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 16, 2024
Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis.
Journal: Molecular & cellular proteomics : MCP
Published: June 23, 2023
Terminal Uridylyltransferases TUT4/7 Regulate microRNA and mRNA Homeostasis.
Journal: Cells
Published: October 18, 2022
Phosphate-regulated expression of the SARS-CoV-2 receptor-binding domain in the diatom Phaeodactylum tricornutum for pandemic diagnostics.
Journal: Scientific reports
Published: November 19, 2021
Regulation of RNA stability at the 3' end.
Journal: Biological chemistry
Published: September 24, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026